F 0697
Provide safe, appropriate pain management for a resident who requires such services.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review [AES1] the facility failed to provide pain medicine in the form of a
cream (lidocaine) for one out of two sampled residents (Resident 1). This failure potentially caused
Resident 1 pain and further suffering by missed medication administrations.
Residents Affected - Few
Findings:
During a review of Resident 1 ' s admission Record, dated 1/23/2007, indicated Resident 1 had initially
been admitted to the facility on [DATE] with a medical history of stroke (blockage of blood supply in parts of
the brain), quadriplegia (as defined as the dysfunction or loss of motor and sensory function of the cervical
area [AES3] of the spinal cord, leading to partial or total loss of function in the arms legs, trunk and pelvis)
and high blood pressure.
During an interview with Resident 1 on 6/13/24 at 10:38 a.m., Resident 1 stated the medication, Lidocaine
(ointment type cream which when applied relieves pain) Ointment was to be administered two times a day
and it had not been administered for days and the facility was giving excuses like it been refused (by
resident) or it was back ordered. Resident 1 stated when the medication had not been applied, to the
buttocks area and could be painful.
During a concurrent review of Resident 1 ' s, Medication Administration Record and Physician orders, for
the month of Jun, 2024 indicated Resident 1 was administered Lidocaine External Ointment 5%, two times
a day (06:30 am, 9pm) on 6/1/24. The Medication Administration Record indicated on 6/2/24 both am and
pm doses had a code of nine (indicating the medication was not administered), 6/3/24 the am dose
documentation space was left blank, indicating the medication had not been given and at 9 pm, the same
code of 9 was documented. On 6/4/24 at 06:30 am the same code of nine was documented but the 9 pm
dose was documented to be given as ordered.
During a concurrent observation and interview on 6/13/24 at 3:30 pm, at the medication cart , with Licensed
Staff A, Licensed Staff A indicated by pulling out a drawer that Resident 1 had a tube of Lidocaine cream
with Residents 1 ' s name and prescription information on the tube. The tube filled with medication
appeared to be almost full and when Licensed Staff A was asked when would the medication be
re-ordered, Licensed Staff A indicated by gesturing, using the thumb and index finger when the top was
approximately 1/3 left of the medication and would be re-ordered so it would not run out. Licensed Staff A
reviewed the Medication Administration Record, dated 6/1/24 to 6/4/24 and stated the code documented on
6/2/24, 6/3/24 and 6/4/24 meant the medication had not been administered.
Licensed Staff A indicated on the Medication Administration Record, dated 6/1/24 to 6/4/24 was reviewed
and stated the code documented on 6/2/24, 6/3/24 and 6/4/24, indicated the code meant the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
055268
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055268
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sonoma Post Acute
678 2nd Street West
Sonoma, CA 95476
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
medication had been re-ordered but had not yet arrived at the facility. Licensed Staff A stated Resident 1
had received the medication on 6/4/24 at the 9 pm dose but had missed the 6:30 am dose.
Licensed Staff A could not explain when the medication had been originally re-ordered but there was
documentation to indicate the medication had to be re-ordered for a second time on 6/3/24 and was
delivered after the 6:30 am dose and prior to the 9 pm. dose.
During an interview on 6/13/24 at 3:35 pm. with Director of Nursing (DON), DON indicated the Lidocaine
cream for Resident 1 had been ordered on 6/1/24 (when last dose administered) and then had to be
re-ordered again, on 6/3/24 and was then delivered on 6/4/24 (this timeline explains why Resident 1 did not
receive the doses of lidocaine cream). DON could not explain why the medication had not been re-ordered
prior to the medication running out and would not explain the outcome of not having the medication.
There was no documentation that indicated when did Resident 1 ran out of Lidocaine cream or when the
Lidocaine cream was ordered to the pharmacy.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055268
If continuation sheet
Page 2 of 2